Europe Thalassemia Market and Competitive Landscape - 2017

  • ID: 4377751
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Thalassemia Market and Competitive Landscape - 2017, provides comprehensive insights into Thalassemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Thalassemia market size and drug sales. This research also provides insights into Thalassemia epidemiology and late stage pipeline.

The report is classified into nine sections - Thalassemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Thalassemia pipeline insights covering late stage clinical trials pipeline; Thalassemia prevalence trends by countries; Thalassemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Thalassemia pipeline: Find out the drugs in clinical trials for Thalassemia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Thalassemia epidemiology: Find out the prevalence of Thalassemia by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Thalassemia products: Identify key products marketed and prescribed for Thalassemia by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Thalassemia market size: Find out the market size for Thalassemia drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Thalassemia drug sales: Find out the sales of Thalassemia drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Thalassemia drugs sales forecast: Sales forecast for Thalassemia drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Thalassemia market share analysis: Find out the market shares of Thalassemia drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Thalassemia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Thalassemia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Thalassemia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Thalassemia: Disease Overview
1.1. Thalassemia Symptoms
1.2. Thalassemia Etiology
1.3. Thalassemia Diagnosis
1.4. Thalassemia Treatment Options

2. Thalassemia Pipeline Insights
2.1. Thalassemia Phase 3 Clinical Trials
2.2. Thalassemia Phase 2 Clinical Trials
2.3. Thalassemia Phase 1 Clinical Trials

3. Thalassemia Epidemiology Analysis

4. Germany Thalassemia Market Insights
4.1. Marketed Products for Thalassemia in Germany
4.2. Germany Thalassemia Market Size & Forecast
4.3. Germany Thalassemia Product Sales Forecast
4.4. Germany Thalassemia Market Share Analysis

5. France Thalassemia Market Insights
5.1. Marketed Products for Thalassemia in France
5.2. France Thalassemia Market Size & Forecast
5.3. France Thalassemia Product Sales Forecast
5.4. France Thalassemia Market Share Analysis

6. Italy Thalassemia Market Insights
6.1. Marketed Products for Thalassemia in Italy
6.2. Italy Thalassemia Market Size & Forecast
6.3. Italy Thalassemia Product Sales Forecast
6.4. Italy Thalassemia Market Share Analysis

7. Spain Thalassemia Market Insights
7.1. Marketed Products for Thalassemia in Spain
7.2. Spain Thalassemia Market Size & Forecast
7.3. Spain Thalassemia Product Sales Forecast
7.4. Spain Thalassemia Market Share Analysis

8. UK Thalassemia Market Insights
8.1. Marketed Products for Thalassemia in UK
8.2. UK Thalassemia Market Size & Forecast
8.3. UK Thalassemia Product Sales Forecast
8.4. UK Thalassemia Market Share Analysis

9. Europe Thalassemia Market Insights
9.1. Europe Thalassemia Market Size & Forecast
9.2. Europe Thalassemia Product Sales Forecast
9.3. Europe Thalassemia Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Thalassemia Phase 3 Clinical Trials, Global, 2017
Table 2: Thalassemia Phase 2 Clinical Trials, Global, 2017
Table 3: Thalassemia Phase 1 Clinical Trials, Global, 2017
Table 4: Thalassemia Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Thalassemia in Germany, 2017
Table 6: Germany Thalassemia Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Thalassemia Product Sales ($mn), 2012 - 2021
Table 8: Germany Thalassemia Market Trends, 2012 - 2021
Table 9: Marketed Products for Thalassemia in France, 2017
Table 10: France Thalassemia Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Thalassemia Product Sales ($mn), 2012 - 2021
Table 12: France Thalassemia Market Trends, 2012 - 2021
Table 13: Marketed Products for Thalassemia in Italy, 2017
Table 14: Italy Thalassemia Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Thalassemia Product Sales ($mn), 2012 - 2021
Table 16: Italy Thalassemia Market Trends, 2012 - 2021
Table 17: Marketed Products for Thalassemia in Spain, 2017
Table 18: Spain Thalassemia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Thalassemia Product Sales ($mn), 2012 - 2021
Table 20: Spain Thalassemia Market Trends, 2012 - 2021
Table 21: Marketed Products for Thalassemia in UK, 2017
Table 22: UK Thalassemia Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Thalassemia Product Sales ($mn), 2012 - 2021
Table 24: UK Thalassemia Market Trends, 2012 - 2021
Table 25: Europe Thalassemia Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Thalassemia Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Thalassemia Pipeline by Phase (%), Global, 2017
Figure 2: Thalassemia Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Thalassemia Market Size ($mn), 2012 - 2021
Figure 4: Germany Thalassemia Product Sales ($mn), 2012 - 2021
Figure 5: Germany Thalassemia Market Share by Products (%), 2016
Figure 6: Germany Thalassemia Market - Future Market Share (%), 2021
Figure 7: France Thalassemia Market Size ($mn), 2012 - 2021
Figure 8: France Thalassemia Product Sales ($mn), 2012 - 2021
Figure 9: France Thalassemia Market Share by Products (%), 2016
Figure 10: France Thalassemia Market - Future Market Share (%), 2021
Figure 11: Italy Thalassemia Market Size ($mn), 2012 - 2021
Figure 12: Italy Thalassemia Product Sales ($mn), 2012 - 2021
Figure 13: Italy Thalassemia Market Share by Products (%), 2016
Figure 14: Italy Thalassemia Market - Future Market Share (%), 2021
Figure 15: Spain Thalassemia Market Size ($mn), 2012 - 2021
Figure 16: Spain Thalassemia Product Sales ($mn), 2012 - 2021
Figure 17: Spain Thalassemia Market Share by Products (%), 2016
Figure 18: Spain Thalassemia Market - Future Market Share (%), 2021
Figure 19: UK Thalassemia Market Size ($mn), 2012 - 2021
Figure 20: UK Thalassemia Product Sales ($mn), 2012 - 2021
Figure 21: UK Thalassemia Market Share by Products (%), 2016
Figure 22: UK Thalassemia Market - Future Market Share (%), 2021
Figure 23: Europe Thalassemia Market Size ($mn), 2012 - 2021
Figure 24: Europe Thalassemia Product Sales ($mn), 2012 - 2021
Figure 25: Europe Thalassemia Market Share by Products (%), 2016
Figure 26: Europe Thalassemia Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll